David A Rosa Neuroone Medical Technologies Corp (NMTC) insider trading activity

David A Rosa is CEO and President of NEUROONE MEDICAL TECHNOLOGIES Corp. Currently has a direct ownership of 1.16 Million shares of NMTC, which is worth approximately $1.07 Million. The most recent transaction as insider was on Jun 30, 2024, when has been sold 4,697 shares (Common Stock) at a price of $0.8 per share, resulting in proceeds of $3,757. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.16M

2.44% 3M change

112.67% 12M change

Total Value Held $1.07 Million

David A Rosa Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 30 2024	SELL Payment of exercise price or tax liability	$3,757 $0.8 p/Share	4,697 Reduced 0.4%	1,155,661 Common Stock
May 31 2024	SELL Payment of exercise price or tax liability	$2,082 $0.93 p/Share	2,239 Reduced 0.19%	1,160,358 Common Stock
Apr 30 2024	SELL Payment of exercise price or tax liability	$2,530 $1.13 p/Share	2,239 Reduced 0.19%	1,162,597 Common Stock
Apr 21 2024	SELL Payment of exercise price or tax liability	$22,623 $1.15 p/Share	19,673 Reduced 1.66%	1,164,836 Common Stock
Mar 31 2024	SELL Payment of exercise price or tax liability	$2,686 $1.2 p/Share	2,239 Reduced 0.19%	1,184,509 Common Stock
Feb 29 2024	SELL Payment of exercise price or tax liability	$2,709 $1.21 p/Share	2,239 Reduced 0.19%	1,186,748 Common Stock
Feb 18 2024	BUY Grant, award, or other acquisition	-	663,497 Added 35.82%	1,188,987 Common Stock

Jan 31 2024	SELL Payment of exercise price or tax liability	$2,798 $1.25 p/Share	2,239 Reduced 0.42%	525,490 Common Stock
Dec 31 2023	SELL Payment of exercise price or tax liability	$3,537 $1.58 p/Share	2,239 Reduced 0.42%	527,729 Common Stock
Nov 30 2023	SELL Payment of exercise price or tax liability	$3,246 $1.45 p/Share	2,239 Reduced 0.42%	529,968 Common Stock
Nov 02 2023	SELL Payment of exercise price or tax liability	$3,604 $1.61 p/Share	2,239 Reduced 0.42%	532,207 Common Stock
Oct 31 2023	SELL Payment of exercise price or tax liability	$2,015 $0.9 p/Share	2,239 Reduced 0.42%	534,446 Common Stock
Sep 30 2023	SELL Payment of exercise price or tax liability	$1,992 $0.89 p/Share	2,239 Reduced 0.42%	536,685 Common Stock
Aug 31 2023	SELL Payment of exercise price or tax liability	$1,903 $0.85 p/Share	2,239 Reduced 0.41%	538,924 Common Stock
Jul 31 2023	SELL Payment of exercise price or tax liability	$2,283 $1.02 p/Share	2,239 Reduced 0.41%	541,163 Common Stock
Jun 30 2023	SELL Payment of exercise price or tax liability	$2,686 $1.2 p/Share	2,239 Reduced 0.41%	543,402 Common Stock
May 31 2023	SELL Payment of exercise price or tax liability	$2,709 $1.21 p/Share	2,239 Reduced 0.41%	545,641 Common Stock
Apr 30 2023	SELL Payment of exercise price or tax liability	$3,448 $1.54 p/Share	2,239 Reduced 0.41%	547,880 Common Stock
Apr 21 2023	BUY Grant, award, or other acquisition	-	91,500 Added 14.26%	550,119 Common Stock
Mar 31 2023	SELL Payment of exercise price or tax liability	$3,604 $1.61 p/Share	2,239 Reduced 0.49%	458,619 Common Stock
Feb 03 2023	SELL Payment of exercise price or tax liability	$79,012 $1.47 p/Share	53,750 Reduced 10.44%	460,858 Common Stock
Feb 03 2022	BUY Grant, award, or other acquisition	-	250,000 Added 32.7%	514,608 Common Stock

Also insider at

BTCY

BIOTRICITY INC. Healthcare

Director

BRTX

BioRestorative Therapies, Inc. Healthcare

HCTI

Healthcare Triangle, Inc. Healthcare

Director

DAR

David A Rosa

CEO and President

Pleasanton, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NMTC shares.

Notify only if

Value

Insider Trading

Get notified when an Neuroone Medical Technologies Corp insider buys or sells NMTC shares.

Notify only if

Operation

Value

Type

News

Receive news related to NEUROONE MEDICAL TECHNOLOGIES Corp

Track Activities on NMTC

Account